SLC22A17 and heart failure: As circulating LCN2 increases in patients with heart failure, the production of LCN2 in the heart increases51, and in vitro treatment of cardiomyocytes with LCN2 causes iron accumulation and oxidative stress through increased 24p3R expression52,53.